Rohto Pharmaceutical completed the share acquisition of Thann Oryza and became its parent company on May 29, 2026. The impact on future earnings is under review, and additional information will be disclosed when available.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4527","jir_company_name":"Rohto Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-05-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4527-20260529-01.pdf","jir_short_summary":"Rohto Pharmaceutical completed the share acquisition of Thann Oryza and became its parent company on May 29, 2026. The impact on future earnings is under review, and additional information will be disclosed when available.","jir_summary":"### Performance Overview\nRohto Pharmaceutical completed the share acquisition of Thann Oryza Co., Ltd. on May 29, 2026, thereby realizing its subsidiary. This aims to expand its business portfolio and strengthen market competitiveness. The impact on consolidated performance is currently under review, and detailed figures and forecasts have not been announced.\n\n### Future Outlook\nThe impact of the share acquisition on future performance is currently undecided, but it will be promptly disclosed once additional information is obtained. Investors should recognize that the subsidiary acquisition is part of the company's strategic initiatives and pay attention to future earnings trends.","jir_financial_highlights":"Share Acquisition Completion Date: 2026-05-29 (Unknown)\nFuture Outlook: Unknown (Unknown)","jir_category":"","jir_hashtags":"#RohtoPharmaceutical, #IRRelated, #JapanStocks","jir_key_figures":"Share acquisition completion date: 2026-05-29\nFuture outlook: Under review\nSpecific financial figures related to the subsidiary acquisition are unknown","jir_meta_title":"[Rohto Pharmaceutical] Completion of Subsidiary Acquisition | May 2026","jir_meta_description":"Rohto Pharmaceutical completed the share acquisition of Thann Oryza on May 29, 2026, and achieved subsidiary status. The impact on future earnings is under review, with attention to additional information.","jir_og_title":"[Rohto Pharmaceutical] Completion of Subsidiary Acquisition | May 2026","jir_og_description":"Rohto Pharmaceutical completed the share acquisition of Thann Oryza, establishing a subsidiary. Future earnings trends are attracting attention.","jir_og_image_url":"","jir_chart_data_collection":"","ir_related_company":7770,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-55538","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n